September 24-26, 2002
Anaheim Convention Center
Anaheim, California USA


The medical industry: with reported annual sales of $57 billions is now bigger than the steel industry, and continues to be one of the most dynamic sectors of U.S. high technology enterprises. California alone represents 19 percent of the nation’s medical instruments industry.
You may want to check:
http://www.csulb.edu/~druz/wesconbme
http://www.csulb.edu/~druz/wesconmedical/
http://www.csulb.edu/~druz/wesconemb
http://www.csulb.edu/~druz/BMEBIOTECH
This
Applications Conference is a part of Wescon
2002 and it will be held
on Tuesday, September 24, 2002
Anaheim Convention Center, Anaheim, California USA
Presentations: BioImmune.pdf,
IEEE – Region 6 EMBS Event - Session SP7
Tuesday, September 24, 2002, 9:00 am - 5:00 pm
Biomedicine and Bioengineering - The Future of Medicine
(Organized by IEEE Region 6 Engineering in Medicine and Biology Society)
Fee: No Charge
Co-Organizers: Dr. Christopher Druzgalski, Professor, Electrical Engineering
Department, California State University, Long Beach and Mr. Jack K. Iverson,
IEEE - Engineering in Medicine & Biology Society, SAC University Liaison.
Region 6, IEEE LAC - Biomedical and Bioengineering=s Academic and Technology
Applications Conference 2002 will explore the coming together of medicine,
engineering and biology, and how this has changed the way medicine is
practiced. Computer-aided surgery, or robotic surgeries including remote
surgery, imaging techniques such MRI, CT, PET and other, joint or denture
replacement with a computer directed joint or denture matching, optical
sensors for the blind, spinal cord bridges, and on miniature level
nanotechnology and MEMS and many of other devices are a small part of the
biomedical progress. This dynamic progress is the result of the fusion of
medicine, engineering and biology, aided by aerospace military technology and
the growth in the biological sciences. Biomedical engineering and
bioengineering programs exist or are being implemented at many universities
with the help of academic partnerships with biotech and other companies
throughout the world. IEEE's Engineering in Medicine and Biology Society (EMBS)
and the Biomedical Engineering Society (BMES) are professional organizations
that are providing leadership in these fields, and are serving as a catalyst
for bringing diverse fields of science together to give mankind improved
quality and extended life.
Program (Tentative Schedule)
Session AM
9:00 – 9:30. Informal get-together
Cochairs: Dr. David Z. D’Argenio, and Warren S. Grundfest, M.D., FACS
9:30 – 9:50. The Alfred E. Mann Institute for Biomedical Engineering at USC
, Dr. David Z. D’Argenio, Professor and Chair, Dept. of Biomedical
Engineering, USC, Alfred Mann Biomedical Engineering Institute.
The Alfred E. Mann Institute for Biomedical Engineering at USC was established
in September 1998, with the goal of fostering the development and
pre-commercialization of medical devices and other biomedical technologies to
improve human health. To accomplish its goal, AMI-USC collaborates with USC
faculty from biomedical engineering and other departments to conduct
use-directed research aimed at identifying, developing, validating and
transitioning to private industry new concepts for use in promoting public
health. The resources, infrastructure and in-house expertise of AMI-USC
enhance the Biomedical Engineering Department's ability to recruit outstanding
biomedical engineering researchers and educators, and provide our students
experiences closer to those that they will encounter in the biomedical device
and diagnostics industry.
9:50 – 10:10. New Biomedical Engineering Tools and Computer/Software-Aided
Surgery, Warren S. Grundfest, M.D., FACS, Chair, Biomedical Engineering /
Professor, Electrical Engineering, UC, Los Angeles.
Minimally invasive surgery has revolutionized patient care, decreased the need
for large incisions, dramatically reduced hospital stay and improved patient
outcome. Current generation instruments are designed without interactive
capacity and provide no feedback or sensory information to the user. As
minimally invasive surgery evolves, tools that provide haptic feedback,
optical diagnostics, and location information must be developed as an
integrated system.
10:10 – 10:30. Legal and Ethical Issues in the Engineering of New
Biomedical Technologies, Dr. Andrea K. Scott, Consultant, Bioethics and
Regulatory Affairs.
This presentation will explain and illustrate by reference to case law or
precedent, certain fundamental legal concepts including civil and criminal
liability, negligence, strict liability and intellectual property rights.
Practical means by which engineers may assess, mitigate and eliminate
potential legal exposure will be offered. The meaning, scope and function of
bioethics as well as this new field's relevance to engineers involved in the
development of new biomedical technologies will be introduced.
10:30 – 10:50. Planetary Protection: Preventing Space Probes from
Transporting Microbes to and from the Planets, Mr. Stephen F. Beverburg,
Member, Engineering Staff, Biotechnology and Planetary Protection Group, Jet
Propulsion Laboratory, California Institute of Technology
This talk will be a brief introduction to planetary protection as required by
international treaty and NASA policies, as well as how it is performed at JPL
with mention of some possible crossover technologies.
10:50 – 11:10. Experiences in Rehabilitation Engineering Education
Programs, Dr. Samuel E. Landsberger, Sc.D., Professor, Mechanical
Engineering & Kinesiology, Cal State, LA and Director, Rehabilitation
Engineering Program, Rancho Los Amigos National Rehabilitation Center.
An educational framework has been created at the Rehabilitation Engineering
Program at Rancho Los Amigos National Rehabilitation Center to expose students
from traditionally disadvantaged backgrounds to the field of Rehabilitation
Engineering and provide a stimulating, hands-on learning experience. Hands-on
Experiences in Rehabilitation Engineering (HERE) has now completed its fourth
academic year in partnership with CSULA, a nationally recognized, leading-edge
minority education institution. The HERE Program provides direct contact
between students and individuals with disabilities in the context of team
design projects. Successive projects build upon earlier student work to refine
designs for manufacture as potential products to benefit people with
disabilities. The HERE program is a problem-based curriculum. The program
comprises lectures, reading, site visits and team - based design work to
introduce students to the fundamentals of R.E. in the context of direct
exposure to human problems. The thesis driving this effort is that students'
analytical and creative energies are evoked and focused as they work together
in design teams to study and address the needs of individuals with orthopedic
disabilities including muscular weakness, spinal cord injury or limb
deficiencies. Mentoring and teamwork activities are integral elements of the
program. HERE has collaborated with community-based organizations including a
highly successful violence prevention program called LA Teens-on-Target (based
at Rancho Los Amigos National Rehabilitation Center) as well as senior centers
in the surrounding community. Multi-year participation in the HERE program
benefits student alumni as they deepen their knowledge, hone design skills and
gain teaching experience as they mentor the incoming students. HERE also
includes a student outreach effort to high schools and middle schools in
disadvantaged communities, employing student mentors to introduce youngsters
to the joys of creative engineering.
11:10 – 11:30. Designing and Manufacturing Rehabilitation Systems, Mr.
Leonard Zerlin, Sr. Engineer (Retired), Hughes Aircraft.
This presentation will explore the design and manufacture of innovative
mechanical devices to aid the handicapped and maintain quality of life for
those who must face a life of diminished physical capacities.
11:30 – 11:50. When Engineers and Biologists Work Together, Dr. Larry
Baresi, Associate Professor of Biology, California State University,
Northridge.
Each spring Biomedical Engineering II is offered as an interdisciplinary
course with the goal of acquainting science and engineering students with each
other’s methods, skills and abilities. The course is divided into
introduction, subject overview, application, analysis, re-evaluation and
submission. It was hoped that through this sequence students could familiarize
themselves with the evolutionary process of interdisciplinary devise
development. This past semester the class divided itself into two groups one
working on the development of magnetic spheres for the early identification
and treatment of lung cancer while the other worked on the development of
devices for male contraception and incontinence. After a couple of weeks each
individual gave an informal presentation outlining the direction of their
project. This was then followed by presentations where the biologist presented
the engineer’s work and the engineers presented the biologist’s work. After
each presentation critical discussions were undertaken by all members of the
class, and based on these discussions new data was obtained from interviews,
library searches, internet searchers and research papers. This material was
presented with new proposals being made as older ones were found to be not
viable. Through this process, students discovered how difficult it was to
present their ideas to others with dissimilar backgrounds and came to
understand that each discipline had something to offer.
Break, Wescon Exhibits
Session PM
Cochairs: Dr. Geert W. Schmid-Schonbein and Dr. Brian Rasnow
1.00 – 1:30 A Bioengineering Analysis of Inflammation in the Cardiovascular
System, Dr. Geert W. Schmid-Schonbein, Professor, Department of
Bioengineering, Whitaker Institute for Biomedical Engineering, UC, San Diego.
Cardiovascular diseases are accompanied by cell activation and non-infectious
inflammation. Inflammation is accompanied by mild cell dysfunction but can
reach full organ failure. While many proposals seek to minimize inflammation,
few serve to understand the origin of inflammation - which will be the topic
of this presentation.
1.30 – 1:50 Biomedical Engineering in Pharmaceutical R&D, Dr. Brian Rasnow,
Research Scientist, Research & Automation Technologies, Amgen, Inc.
Discovery of new pharmaceuticals (proteins, antibodies or small molecules)
involves a tremendous amount of multidisciplinary effort. The critical role
biomedical engineers play in the early stages of drug discovery research at
Amgen and some of the challenges recent BME graduates face in this industrial
setting will be discussed.
1.50 – 2:10 ETDA Vascular ChelationTherapy, Sir Arnold Takemoto,
President and Founder, BioImmune, Inc.
The role of heavy metal detoxification in the prevention and/or treatment of
heart disease and cancers is paramount for optimum healing or prevention. A
clinical study utilizing a unique oral detoxifying concentrate containing true
disodium EDTA was utilized as a provocation, detoxifying agent for a sixteen
patient clinical trial. Significant quantities of heavy metals were excreted
versus each patient's baseline collection. A surprising outcome of the study
was the remarkable clinical healing in severe coronary artery disease and
increase in brain acuity in patients after the study.
Presentation
2.10 – 2:30 Are We Ready for Microwave Hypothermia?, Dr. Boguslaw Kuszta,
ChE Undergraduate Laboratories Director, California Institute of Technology.
The "impossibility" of a microwave hyperthermia results from two paradigms
embedded in physics. The first paradigm says that the effective penetration
depth for microwaves is of the order of one millimeter or less. The second
describes a theoretical limit for focusing of electromagnetic (EM) waves. Both
paradigms are not true. Appropriately tailored microwave pulses can
effectively penetrate the tissue at the depth of centimeters. Also, there is
no limit for focusing of EM radiation, provided that both electromagnetic
parameters characterizing the medium: permittivity (e) and permeability (µ)
are negative. Theoretical calculations and experiments proved that such an
unusual situation is possible in a living tissue.
2.30 – 2:50 Medical Data Transfer via USB Over Ethernet Using TCP/IP, Bob
Ward, Brian Gonzales, John Barnett, Ramsey Beaini, CSCE Dept., California
State University, Long Beach.
TCP/IP and USB have become standard protocols for use in the computer
industry. With the escalating interest in home screening of patients, we will
be seeing an increased number of vendors providing home monitoring
instrumentation that uses the Internet as its link to the medical
professional. This paper will present an overview of the hardware/software
considerations necessary to provide Ethernet connectivity via the Universal
Serial Bus (USB) focusing on its application in medical instrumentation
industry. The paper will further look at the hardware requirements necessary
to interface the USB to an embedded processor, which in turn will access the
Internet via Ethernet using TCP/IP. The use of several different embedded
processors (8051, 68HC12 and ARM) for this application will be discussed as
well as its applications.
2.50 – 3:10 Developments in Neurological BME, Dr. Cynthia Husted,
Director, Center for the Study of Neurodegenerative Disorders, University of
California, Santa Barbara.
A variety of technical developments in central nervous system (CNS) BME will
be presented. Macroscopic to microscopic CNS structure and function will be
reviewed with results from techniques including in vivo magnetic resonance
spectroscopic imaging, solid state magic angle NMR spectroscopy, fluorescence
microscopy of Langmuir monolayers, confocal microscopy of cerebellar slice
cultures, atomic force microscopy of brain lipid assemblies and of CNS
progenitor cells, and evaporative light scattering HPLC for quantitative
analysis. Such developments are increasing our understanding of CNS structure
and function and changes in neurodegenerative disorders. An emphasis on myelin
structure and demyelination will be presented, though the technical approaches
may be applied to other neurodegenerative disorders, including Alzheimer’s
disease, Parkinson’s disease, spinal cord injury and others.
3:10 - 3:30 Overview of the New Wonder Years of Medical Engineering and
Biology, Mr. Jack K. Iverson, IEEE - Engineering in Medicine & Biology
Society, SAC University Liaison.
During this presentation, a fifteen-minute video showing teams at biomedical
engineering colleges, medical schools, biotech companies and hospitals that
will demonstrate orthopedic implants, heart devices (defib implant,
pacemakers, etc.), preventing accidents using biomechanics and the use of
licensed clinical engineers in hospitals.
3.30 – 3:50 Roundtable Discussion Moderated by Dr. Willis G. Downing,
Jr., Professor, Dept. of Electrical and Computer Engineering, California State
University, Northridge, College of Engineering and Computer Science.
3.50 – 4:10 Selected components and subsystems technology issues in medical
electronics, and Session Wrap-Up. Dr. Christopher Druzgalski, IEEE
Los Angeles Council, Engineering in Medicine and Biology Section.
Current trends in health care delivery systems related to long term patient
monitoring, progressive home health care, rapid delivery of health care and
enhanced diagnosis at the point of need, such as a battlefield or an accident,
or organ/function replacement mechanisms define technological demands and
research efforts. In particular, these ever expanding spectrum of diagnostic,
therapeutic, or functional (such as tooth implantable cell phone or
implantable identity chips) devices and systems place particular demands for
passive and active component design, their physical characteristics,
reliability and performance. The hybrid and ASIC design are common in a
variety of pacemakers, hearing aids, control systems in prosthetic devices
from artificial limbs, or systems for stimulation of selected muscles or
organs. However, the discrete components often set the design limits.
The presentation will focus on emerging component applications and demand for
new developments which will allow to blend medical and engineering advances.
4.10 – 5:00 Informal networking, Wescon Exhibits
If you have any comments or questions concerning these sessions, please contact "druz wescon"
or Jack K. Iverson <SeaEagl@aol.com>